ストックスクリーナーアプリを入手
208.99
0.27%
0.57
アフターアワーズ：
209.00
0.010
+0.00%
Abbvie Inc (ABBV) 最新ニュース
Why AbbVie Is a No-Brainer Stock to Buy on the Dip - AOL.com
Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight - GlobeNewswire Inc.
AbbVie Steps Deeper Into Obesity Market With New Phase 1 ABBV-295 Trial - TipRanks
AbbVie’s Head-to-Head Psoriasis Study Sets Up New Catalyst for ABBV Investors - TipRanks
ABBV: Abbott Laboratories Reports In-Line EPS and Strong Revenue Beat - GuruFocus
Nations Financial Group Inc. IA ADV Has $4.88 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Lbp Am Sa Purchases 8,678 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie eases the pain with $745m licensing deal - BioXconomy
Cwm LLC Boosts Holdings in AbbVie Inc. $ABBV - MarketBeat
Diversified Management Inc. Takes Position in AbbVie Inc. $ABBV - MarketBeat
Adelphi Trust Co Makes New Investment in AbbVie Inc. $ABBV - MarketBeat
Operating expenses (excl. COGS) of AbbVie, Inc. – BSESOF:4AB - TradingView — Track All Markets
Evercore ISI Tweaks AbbVie (ABBV) Estimates, Lowers Price Target Marginally - Yahoo Finance
Spectrum Asset Management Reduces AbbVie Stake - National Today
NSCLC Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | AbbVie, AstraZeneca and Daiichi Sankyo, Shanghai Henlius Biotech, Moderna Therapeutics/ Merck, BeyondSpring, Cullinan - Barchart.com
RemeGen (09995.HK) Receives USD650M Upfront Payment from AbbVie for RC148 - AASTOCKS.com
AbbVie Inc. $ABBV Shares Purchased by Farther Finance Advisors LLC - MarketBeat
Bingham Private Wealth LLC Purchases Shares of 5,019 AbbVie Inc. $ABBV - MarketBeat
Franklin Income Focus ETF's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie Inc.: - marketscreener.com
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
AbbVie Inc. stock (US00287Y1091): Is its immunology dominance strong enough to unlock new upside? - AD HOC NEWS
AbbVie (NYSE:ABBV) Shares Up 1.9%Should You Buy? - MarketBeat
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
BRAF Mutated Non-small Cell Lung Cancer Market: Rapid Increment Driven by Innovation by 2036 – DelveInsight | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati Therapeutics - Barchart.com
Abbvie nabs two Nav1.8 pain projects from Haisco in $745M deal - BioWorld News
Could AbbVie Crash Lilly's Weight‑Loss Party? - The Globe and Mail
AbbVie Inc. stock (US00287Y1091): Is immunology dominance strong enough to unlock new upside? - AD HOC NEWS
ABBV stock shows mixed momentum on neutral MACD reading: weekly review - Traders Union
Natural Investments Trims Stake in AbbVie - National Today
JM2 Capital Inc. Buys Shares of 2,519 AbbVie Inc. - National Today
Erin Lichy Gets Real About Her Natrelle® Breast Augmentation - AbbVie News Center
Erin Lichy shares her breast augmentation story in Natrelle campaign - Stock Titan
Natural Investments LLC Decreases Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Rede Wealth LLC - MarketBeat
Haisco Pharma strikes deal with AbbVie to develop novel pain medicines - The Pharma Letter
AbbVie Ovarian Cancer Data And Pain Deal Extend Long Term Story - Yahoo Finance
What is behind AbbVie stock's recent drop in value today - Traders Union
AbbVie’s Elahere succeeds in Phase II platinum-sensitive ovarian cancer trial - Yahoo
Haisco Grants AbbVie Exclusive Rights to Advance Novel Pain Medicines - Contract Pharma
Abbvie licenses ex-China rights to Haisco pain compounds - BioWorld News
Will AbbVie's Neuroscience Franchise Aid Top-line Growth in Q1? - Yahoo Finance
AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid - Pharmaceutical Technology
AbbVie (ABBV) Ends Development Agreement, CollPlant Eyes New Opp - GuruFocus
CollPlant announces termination of development agreement with AbbVie - TipRanks
CollPlant ends AbbVie deal, cuts workforce by 50% - Investing.com Canada
AbbVie ends CollPlant (NASDAQ: CLGN) filler pact as CollPlant slashes workforce 50% - Stock Titan
DB&C Advisors, LLC's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie (ABBV) Partners with Haisco for Pain Therapy Development - GuruFocus
Haisco Pharmaceutical Group Co., Ltd. Enters Exclusive License Agreement with AbbVie - marketscreener.com
AbbVie, Inc. Trade Ideas — BSESOF:4AB - TradingView — Track All Markets
Haisco licenses pain drug candidates to AbbVie for $745 million By Investing.com - Investing.com Canada
Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain - Yahoo Finance
AbbVie Inc. (ABBV): A Bull Case Theory - MSN
AbbVie (ABBV) to Present Promising Trial Results at SGO Annual M - GuruFocus
AbbVie stock falls 2.05% as new ovarian cancer data shared at SGO meeting - Traders Union
Sumitomo Mitsui Trust Group Trims AbbVie Stake - National Today
AbbVie Showcases Late?Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx in Platinum?Sensitive Ovarian Cancer at SGO 2026 - Investing News Network
Significant BD revenue contribution: Hisun Q1 net profit forecast increases up to nearly 11 times. Another major BD deal worth $745 million signed with AbbVie. - 富途牛牛
AbbVie ovarian cancer drug shows 62.7% response rate in trial - Investing.com
Robeco Institutional Asset Management B.V. Trims Stake in AbbVie Inc. $ABBV - MarketBeat
Haisco Pharmaceutical Signs Licensing Agreement With AbbVie Group - TradingView — Track All Markets
AbbVie's ELAHERE Demonstrates Unexpected PSOC Effectiveness, Boosting Anticipated Expansion - Bitget
AbbVie stock price forecast: sellers in control as ABBV fails to hold above support - Traders Union
Massachusetts Financial Firm Trims Stake in AbbVie - National Today
-2.05% for AbbVie stock as renewed selling keeps shares below key resistance - Traders Union
Factory Mutual Insurance Co. Decreases AbbVie Stock Position - National Today
AbbVie (ABBV) Receives a Buy from RBC Capital - The Globe and Mail
Appreciation Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
Is It Too Late To Consider AbbVie (ABBV) After The Recent Share Price Pullback? - Yahoo Finance
INVESCO Health Care Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
0.37%
0.34%
大文字化:
|
ボリューム (24 時間):